{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:13:40Z","timestamp":1788650020779,"version":"build-2803163510"},"reference-count":37,"publisher":"Baskent University","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.6002\/ect.2021.0282","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:53:15Z","timestamp":1637715195000},"page":"1156-1162","source":"Crossref","is-referenced-by-count":2,"title":["Factors Associated With Cytomegalovirus Infection in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Prospective Single-Center Study"],"prefix":"10.6002","volume":"19","author":[{"given":"Marko","family":"Jankovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kne\u017eevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"\u0106upi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Vuji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Simi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Ze\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borko","family":"Gobelji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The \"silent\" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102. doi:10.1128\/CMR.00062-12","DOI":"10.1128\/CMR.00062-12"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Maltezou HC, Kafetzis DA, Abisaid D, Mantzouranis EC, Chan KW, Rolston KV. Viral infections in children undergoing hematopoietic stem cell transplant. Pediatr Infect Dis J. 2000;19(4):307-312. doi:10.1097\/00006454-200004000-00009","DOI":"10.1097\/00006454-200004000-00009"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol. 2013;6:94. doi:10.1186\/1756-8722-6-94","DOI":"10.1186\/1756-8722-6-94"},{"key":"ref3","unstructured":"4. PDQ Pediatric Treatment Editorial Board. PDQ Childhood Hematopoietic Cell Transplantation. Bethesda, MD: National Cancer Institute. Updated July 13, 2021. Accessed June 13, 2019. https:\/\/www.cancer.gov\/types\/childhood-cancers\/child-hct-hp-pdq"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Castagnola E, Cappelli B, Erba D, Rabagliati A, Lanino E, Dini G. Cytomegalovirus infection after bone marrow transplantation in children. Hum Immunol. 2004;65(5):416-422. doi:10.1016\/j.humimm.2004.02.013","DOI":"10.1016\/j.humimm.2004.02.013"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Tsao SY, Chang KC, Chen YP, Yeh YM, Su WC, Chen TY. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2011;90(1):113-114. doi:10.1007\/s00277-010-0947-8","DOI":"10.1007\/s00277-010-0947-8"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Manez R, Breinig MC, Linden P, et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis. 1997;176(6):1462-1467. doi:10.1086\/514142","DOI":"10.1086\/514142"},{"key":"ref7","unstructured":"8. European Society for Blood and Marrow Transplantation. Publication Guidelines for Retrospective Studies, Non-Interventional Prospective Trials, and Prospective Clinical Trials of the European Society for Blood and Marrow Transplantation. June 1, 2012. Updated July 4, 2020. Accessed May 5, 2020. https:\/\/www.ebmt.org\/research\/ebmt-publications"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Razonable RR, Humar A; AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:93-106. doi:10.1111\/ajt.12103","DOI":"10.1111\/ajt.12103"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Ljungman P, Boeckh M, Hirsch HH, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64(1):87-91. doi:10.1093\/cid\/ciw668","DOI":"10.1093\/cid\/ciw668"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Jakovljevic A, Knezevic A, Nikolic N, et al. Herpesviruses viral loads and levels of proinflammatory cytokines in apical periodontitis. Oral Dis. 2018;24(5):840-846. doi:10.1111\/odi.12829","DOI":"10.1111\/odi.12829"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Bonon SH, Menoni SM, Rossi CL, et al. Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients. J Infect. 2005;50(2):130-137. doi:10.1016\/j.jinf.2003.11.010","DOI":"10.1016\/j.jinf.2003.11.010"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Dieamant DC, Bonon SH, Peres RM, et al. Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation. BMC Infect Dis. 2013;13:310. doi:10.1186\/1471-2334-13-310","DOI":"10.1186\/1471-2334-13-310"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. de Campos Dieamant D, Bonon SH, Prates LC, Belangelo VM, Pontes ER, Costa SC. Active human cytomegalovirus infection and glycoprotein b genotypes in Brazilian pediatric renal or hematopoietic stem cell transplantation patients. Braz J Microbiol. 2010;41(1):50-58. doi:10.1590\/S1517-838220100001000010","DOI":"10.1590\/S1517-83822010000100010"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Inagaki J, Noguchi M, Kurauchi K, Tanioka S, Fukano R, Okamura J. Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia. Biol Blood Marrow Transplant. 2016;22(2):300-306. doi:10.1016\/j.bbmt.2015.09.006","DOI":"10.1016\/j.bbmt.2015.09.006"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Yoon HS, Lee JH, Choi ES, et al. Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: a retrospective study of the risk factors. Pediatr Transplant. 2009;13(7):898-905. doi:10.1111\/j.1399-3046.2008.01084.x","DOI":"10.1111\/j.1399-3046.2008.01084.x"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Qayed M, Khurana M, Hilinski J, et al. Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2015;62(2):364-366. doi:10.1002\/pbc.25237","DOI":"10.1002\/pbc.25237"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile. Pediatr Blood Cancer. 2009;53(3):453-458. doi:10.1002\/pbc.22060","DOI":"10.1002\/pbc.22060"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Yakushiji K, Gondo H, Kamezaki K, et al. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant. 2002;29(7):599-606. doi:10.1038\/sj.bmt.1703513","DOI":"10.1038\/sj.bmt.1703513"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Chakrabarti S, Mackinnon S, Chopra R, et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood. 2002;99(12):4357-4363. doi:10.1182\/blood.v99.12.4357","DOI":"10.1182\/blood.V99.12.4357"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. George B, Pati N, Gilroy N, et al. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis. 2010;12(4):322-329. doi:10.1111\/j.1399-3062.2010.00504.x","DOI":"10.1111\/j.1399-3062.2010.00504.x"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Goldsmith SR, Slade M, Lawrence SJ, et al. Cytomegalovirus viremia and relapse after haploidentical hematopoietic cell transplantation (Abstract 473). Biol Blood Marrow Transplant. 2016;22(Suppl 3):320. doi:10.1016\/j.bbmt.2015.11.795","DOI":"10.1016\/j.bbmt.2015.11.795"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Jaing TH, Chang TY, Chen SH, et al. Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation. Medicine (Baltimore). 2019;98(4):e14172. doi:10.1097\/MD.0000000000014172","DOI":"10.1097\/MD.0000000000014172"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Ozdemir E, Saliba RM, Champlin RE, et al. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant. 2007;40(2):125-136. doi:10.1038\/sj.bmt.1705699","DOI":"10.1038\/sj.bmt.1705699"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011;11(5):466-474. doi:10.2174\/187152611797636703","DOI":"10.2174\/187152611797636703"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Valadkhani B, Kargar M, Ashouri A, Hadjibabaie M, Gholami K, Ghavamzadeh A. The risk factors for cytomegalovirus reactivation following stem cell transplantation. J Res Pharm Pract. 2016;5(1):63-69. doi:10.4103\/2279-042X.176554","DOI":"10.4103\/2279-042X.176554"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Goldsmith SR, Slade M, DiPersio JF, et al. Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. Haematologica. 2016;101(11):e465-e468. doi:10.3324\/haematol.2016.149880","DOI":"10.3324\/haematol.2016.149880"},{"issue":"4","key":"ref27","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1182\/blood.V67.4.1162.1162","article-title":"Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease","volume":"67","author":"Miller","year":"1986","unstructured":"28. Miller W, Flynn P, McCullough J, et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood. 1986;67(4):1162-1167.","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Schetelig J, Oswald O, Steuer N, et al. Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia. Bone Marrow Transplant. 2003;32(7):695-701. doi:10.1038\/sj.bmt.1704164","DOI":"10.1038\/sj.bmt.1704164"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Takenaka K, Nishida T, Asano-Mori Y, et al. Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Biol Blood Marrow Transplant. 2015;21(11):2008-2016. doi:10.1016\/j.bbmt.2015.07.019","DOI":"10.1016\/j.bbmt.2015.07.019"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300(4):413-422. doi:10.1001\/jama.300.4.413","DOI":"10.1001\/jama.300.4.413"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. van Boven M, van de Kassteele J, Korndewal MJ, et al. Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalence. PLoS Comput Biol. 2017;13(9):e1005719. doi:10.1371\/journal.pcbi.1005719","DOI":"10.1371\/journal.pcbi.1005719"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Sackman AM, Pfeifer SP, Kowalik TF, Jensen JD. On the demographic and selective forces shaping patterns of human cytomegalovirus variation within hosts. Pathogens. 2018;7(1). doi:10.3390\/pathogens7010016","DOI":"10.3390\/pathogens7010016"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Howden BP, Michaelides A, Spelman DW, et al. Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis. Bone Marrow Transplant. 2003;32(8):795-800. doi:10.1038\/sj.bmt.1704230","DOI":"10.1038\/sj.bmt.1704230"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Parry HM, Zuo J, Frumento G, et al. Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immun Ageing. 2016;13:1. doi:10.1186\/s12979-015-0056-6","DOI":"10.1186\/s12979-015-0056-6"},{"key":"ref35","unstructured":"36. Habib K, Lamia T, Amel L, et al. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes. Exp Clin Transplant. 2008;6(1):67-73."},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Yang R, Zhang R, Zhang Y, et al. Risk factors analysis for human cytomegalovirus viremia in donor+\/recipient+ hematopoietic stem cell transplantation. Lab Med. 2020;51(1):74-79. doi:10.1093\/labmed\/lmz030","DOI":"10.1093\/labmed\/lmz030"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T01:57:40Z","timestamp":1637719060000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/current\/2021\/19\/11\/0\/1156\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0282","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}